Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Critical Reviews in Oral Biology & Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Loesche, W.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
10(3):245-275 (1999)     Crit Rev Oral Biol Med
© 1999 SAGE Publications

The Antimicrobial Treatment of Periodontal Disease: Changing the Treatment Paradigm

W.J. Loesche

University of Michigan School of Dentistry, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA

Over the last 100 years, methods of surgical periodontal treatment have enjoyed a history of success in improving oral health. The paradigm of care is based on the "non-specific plaque hypothesis"-that is, the overgrowth of bacterial plaques cause periodontal disease, and the suppression of this overgrowth reduces disease risk. The central feature of this approach to care is the removal of inflamed gingival tissue around the teeth to reduce periodontal pocket depth, thereby facilitating plaque removal by the dentist and by the patient at home. Over the last 30 years, with the recognition that periodontal disease(s) is caused by specific bacteria and that specific antimicrobial agents can reduce or eliminate the infection, a second paradigm has developed. This new paradigm, the "specific plaque hypothesis", focuses on reducing the specific bacteria that cause periodontal attachment loss. The contrast between the two paradigms can be succinctly stated as follows: The antimicrobial therapy reduces the cause, while the surgical therapy reduces the result of the periodontal infection. The specific plaque hypothesis has two important implications. First, with the increasing attention to evidence-based models for prevention, treatment, outcome assessment, and reimbursement of care, increasing attention and financial effort will be channeled into effective preventive and treatment methods. Second, the recent observations that periodontal infections increase the risk of specific systemic health problems, such as cardiovascular disease, argue for the prevention and elimination of these periodontal infections. This review highlights some of the evidence for the specific plaque hypothesis, and the questions that should be addressed if antimicrobial agents are to be used responsively and effectively.

Key Words: Periodontal disease • antimicrobials • clinical trials • metronidazole • clinical outcomes • anaerobes • local delivery devices • compliance.

Critical Reviews in Oral Biology & Medicine, Vol. 10, No. 3, 245-275 (1999)
DOI: 10.1177/10454411990100030101


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JDRHome page
J.A. Banas
Walter Loesche--a Maverick in Translational Research in Dentistry
Journal of Dental Research, December 1, 2009; 88(12): 1092 - 1095.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Wakabayashi, K. Yamauchi, T. Kobayashi, T. Yaeshima, K. Iwatsuki, and H. Yoshie
Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia
Antimicrob. Agents Chemother., August 1, 2009; 53(8): 3308 - 3316.
[Abstract] [Full Text] [PDF]


Home page
ADRHome page
K.-P. Leung, J.J. Abercrombie, T.M. Campbell, K.D. Gilmore, C.A. Bell, J.A. Faraj, and P.P. DeLuca
Antimicrobial Peptides for Plaque Control
Advances in Dental Research, August 1, 2009; 21(1): 57 - 62.
[Full Text] [PDF]


Home page
JDRHome page
J. Cunha-Cruz, P.P. Hujoel, G. Maupome, and B. Saver
Systemic Antibiotics and Tooth Loss in Periodontal Disease
Journal of Dental Research, September 1, 2008; 87(9): 871 - 876.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
K.-P. Leung, T.D. Crowe, J.J. Abercrombie, C.M. Molina, C.J. Bradshaw, C.L. Jensen, Q. Luo, and G.A. Thompson
Control of Oral Biofilm Formation by an Antimicrobial Decapeptide
Journal of Dental Research, December 1, 2005; 84(12): 1172 - 1177.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
W. J. LOESCHE, J. R. GIORDANO, S. SOEHREN, and N. KACIROTI
The nonsurgical treatment of patients with periodontal disease: Results after five years
J Am Dent Assoc, March 1, 2002; 133(3): 311 - 320.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
W. J. Loesche and N. S. Grossman
Periodontal Disease as a Specific, albeit Chronic, Infection: Diagnosis and Treatment
Clin. Microbiol. Rev., October 1, 2001; 14(4): 727 - 752.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. C. Slavkin and B. J. Baum
Relationship of Dental and Oral Pathology to Systemic Illness
JAMA, September 13, 2000; 284(10): 1215 - 1217.
[Full Text] [PDF]